Services

Mission

The PathoQuest mission is to develop proprietary, rapid turn-around-time GMP Next Generation Sequencing (NGS) assays and bioinformatic approaches designed for biologics testing. These advancements accelerate adventitious agent detection and bioprocess characterization, and enables to replace the use of animals in biosafety testing. By enhancing biotesting methods and providing comprehensive biosafety services, we enable the safe and high-quality production of biopharmaceuticals.

SERVICES

Adventitious Virus Testing

Detection of viral contamination within the manufacturing process and beyond.

Identity Confirmation

Genetic characterization of viral and plasmid products for release.

Integration Site Analysis

Characterisation of genetic modifications for clone selection, genetic stability and lot release

Cell Line Characterization

Biosafety screening and stability testing of manufacturing cells.

READ MORE

READ MORE

READ MORE

HLA Genotyping

Characterizing and screening for novel and emerging cell therapies.

In Vivo Replacement

NGS as an ethical alternative to animals in biosafety testing and characterization.

Raw Material Testing

Screening of high-risk inputs such as animal products and media.

READ MORE

READ MORE

READ MORE

Contact us

U.S.

+1 484 212 9360

466 Devon Park Dr
Wayne, PA 19087
United States

Sign up for our latest news

France

+33 (0)1 70 82 17 90

Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France

How can PathoQuest help?

Name(Required)
This field is for validation purposes and should be left unchanged.

U.S.

+1 484 212 9360

466 Devon Park Dr
Wayne, PA 19087
United States

France

+33 (0)1 70 82 17 90

Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France

How can PathoQuest help?

Name(Required)
This field is for validation purposes and should be left unchanged.

Sign up for our latest news